Topical sodium cromoglycate in the treatment of moderate-to-severe atopic dermatitis

Annals of Allergy, Asthma and Immunology

Volumn 81, Issue 5 I, 1998, Pages 452-458

  Moore, Cleveland ^a   Ehlayel, Mohammad S ^a   Junprasert, Jurairat ^a   Sorensen, Ricardo U ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROMOGLYCATE DISODIUM; CYPROHEPTADINE; DRUG VEHICLE; EMOLLIENT AGENT; HYDROCORTISONE; HYDROXYZINE; IMMUNOGLOBULIN E; TRIAMCINOLONE; WATER;

ADOLESCENT; ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; CROSSOVER PROCEDURE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYDROPHILICITY; INFANT; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOLUBILITY; TOPICAL DRUG ADMINISTRATION;

EID: 0031731464     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63145-6     Document Type: Article

References (63)

1. Leyden JE, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 1974;90:525-530.
2. Sampson HA. Role of immediate food hypersensitivity in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol 1983;71:473.
3. Sanda T, Yasue T, Oohashi M, Yasue A. Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol 1992;89: 653-657.
4. Hanifin JM, Schneider LC, Leung DYM. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol 1993;28:189.
5. Younger IR, Harris DWS, Clover GB. Azathioprine in dermatology. J Am Acad Dermatol 1992;25:281-6.
6. Munro CS, Higgins EM, Marks JM, et al. Cyclosporin A in atopic dermatitis: therapeutic effect and effect on allergic reactions are disassociated from each other. Wiener Medizinische Wochenschrift 1991;141:419-423.
7. Sowden JM, Berth-Jones J, Ross JS. Double-blind crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 1991;338: 137.
8. Sheehan MP, Atherton DJ. A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic dermatitis. Br J Dermatol 1992;126:179.
9. Leung DYM, Hirsh RL, Schneider L, et al. Thymopectin therapy reduces the clinical severity of atopic dermatitis. J Allergy Clin Immunol 1990;85:927.
10. Bjorneboe A, Soyland E, Bjorneboe GE. Effect of n-3 fatty acid supplement to patients with atopic dermatitis. J Intern Med Suppl 1989;225:233.
11. Molkhous P, Dupont C, Ketotifen treatment of atopic dermatitis and other of allergy diseases. Allergy 1989;44:117.
12. Wright S, Burton JL. Oral evening primrose seed oil improves atopic eczema. Lancet 1982;ii:1120-2.
13. Stewart JCM, Morse PF, Moss M, et al. Treatment of severe and moderately severe atopic dermatitis with evening primrose oil (Epogram); a multi-center study. J Nutr Med 1991;2:9-15.
14. Falk ES. UV-light therapies in atopic dermatitis. Photodermatol 1985;2:241.
15. Midelfart K, Stenvold SE, Voloden G. Combined UVB and UVA phototherapy of atopic dermatitis. Dermatologica 1985;171:95.
16. Nakagawa H, Both T, Ishibashi Y, et al. Tacrolimus ointment for atopic dermatitis [letter]. Lancet 1994; 344(8926):833.
17. Kimata H, Igarashi M. Topical croraolyn (sodium cromoglycate) treatment of young children with atopic dermatitis. Clin Exp Allergy 1990;20: 281.
18. Cavagni G, Caffarelli C. Sodium cromoglycate in childhood atopic dermatitis treatment. Allergy 1989;44(Suppl 9):124-128.
19. Storm K, Hahr J, Kjellman N-I, Aesterballe O. The occurrence of asthma and allergic rhinitis, atopic dermatitis and urticaria in Danish children born in one year. Ugeskr Laeger 1986;148: 3295.
20. Haider SA. Treatment of atopic eczema in children: clinical trial of 10% sodium cromoglycate ointment. BMT 1977;1:1570.
21. Kimata H, Hiratsuka S. Effect of topical cromoglycate solution on atopic dermatitis: combined treatment of sodium cromoglycate solution with the oral anti-allergic medication, oxatomide. Eur J Pediatr 1994;153:66-71.
22. Lund CC, Browder NC. The estimation of areas of burns. Surg Gynecol Obstet 1944;79:352-358.
23. Kay A, Walsh G, Moqbel R, et al. Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. J Allergy Clin Immunol 1987; 80:1-8.
24. Bissonnette EY, Befus AD. Modulation of mast cell function in the FI tract. In: Wallace JL, ed. The handbook of immunopharmacology. New York, London: Academic Press, 1993: 95-103.
25. Flint KC, Leung KBP, Hudspith BN. The function and properties of human lung mast cells. Respiration 1986; 50(Suppl 2):31-41.
26. Krishnaswamy G, Lakshman T, Miller A, et al. Multifuntional cytokine expression by human mast cells: regulation by T cell membrane contact and glucocorticoids. J Interferon Cytokine Res 1997;17:167-176.
27. Warbrick E, Thomas A, Williams C. The effects of cyclosporin A, dexamethasone and other immunomodulatory drugs on induced expression of IL-3. IL-4 and IL-8 mRNA in a human mast cell line. Toxicology 1997;116: 211-8.
28. Church M, Benyon R, Rees P, et al. Functional heterogeneity of human mast cells. In: Galli S, Austen K, eds. Mast cell and basophil differentiation and function in health and disease. New York: Raven Press, 1989: 161-170.
29. Pearce CA, Greaves MW, Plummer VM, Yamamoto S. Effect of disodium cromoglycate on antigen evoked histamine release from human skin. Clin Exp Immunol 1974;17:437-440.
30. Okayama Y, Church MK. Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells. Int Arch Allergy Immunol 1992;97:216-25.
31. Ting S, Reimann E, Zweiman B. Effects of cromolyn on codeine-induced histamine release in vivo. Allergy 1984;39:493-7.
32. Ting S, Zweiman B, Lavker RM. Cromolyn does not modulate human allergic skin reactions in vivo. J Allergy Clin Immunol 1983;71(1 Part 1):12-7.
33. Phillips T, Kanj L, Washek D, Lew R. Topical cromolyn can modify human allergic skin reactions. Allergy 1996; 51:198-9.
34. McCarthy D, Peppys J. Allergic bronchopulmonary aspergillosis. Clin Allergy 1971;1:415-32.
35. Booij-Noord J, deVries K, Sluiter H, One N. Late bronchial obstruction reaction to experimental inhalation of house dust extract. Clin Allergy 1972; 2:43-61.
36. Nakazaka T, Yoyoda T, Furukawa M, et al. Inhibitory effects of various drugs on dual asthmatic response in wheat flour-sensitive subjects. J Allergy Clin Immunol 1976;58:1-9.
37. Cohan VL, Undem BJ, Fox CC, et al. Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin. Am Rev Respir Dis 1989;140: 951-954.
38. Brattsand R, Linden M. Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Ther 1996;10 Suppl 2:81-90.
39. Hoshino M, Nakamura Y. The effect of inhaled sodium cromoglycate on cellular infiltration into the bronchial mucosa and the expression of adhesion molecules in asthmatics. Eur Respir J 1997;10:858-865.
40. Kimata H, Yoshida A, Ishioka C, Mikawa H. Disodium cromoglycate (DSCG) selectively inhibits IgE production and enhances IgG4 production by human B cell in vitro. Clin Exp Immunol 1991;84:395-399.
41. Hiratsuka S, Yoshida A, Ishioka C, Kimata H. Enhancement of in vitro spontaneous IgE production by topical steroids in patients with atopic dermatitis. J Allergy Clin Immunol 1996;98: 107-113.
42. Loh RK, Jabara HH, Geha RS. Disodium cromoglycate inhibits S mu→S epsilon deletional switch recombination and IgE synthesis in human B cells. J Exp Med 1994;180: 663-671.
43. Sarfati M, Luo H, Delespesse G. IgE synthesis by chronic lymphocytic leukemia cells. J Exp Med 1989;170: 1775-1780.
44. Jabara HH, Ahern DJ, Vercelli D, Geha RS. Hydrocortisone and IL-4 induce IgE isotype switching in human B cells. J Immunol 1991;147: 1557-1560.
45. Wu CY, Sarfati M, Heusser C, et al. Glucocorticoids increase the synthesis of Immunoglobulin E by interleukin 4-stimulated human lymphocytes. J Clin Invest 1991;87:870-877.
46. Daynes RA, Araneo BA. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol 1989;19:2319-2325.
47. Croner S, Fagulund E, Kjellman NI, Leijon I. Sodium cromoglycate in atopic eczema during childhood. Opuscula Med 1982;26:49-50.
48. Thirumoorthy T, Greaves MV. Disodium cromoglycate ointment in atopic eczema. Br Med J 1978;2:500-501.
49. Zachariae H, Afzelius H, Lauberg G. Topically applied sodium cromoglycate in atopic dermatitis. In: Pepys J, Edwards AM, eds. The mast cell: its role in health and disease. Tunbridge Wells: Pitman Medical, 1979: 568-569.
50. Pike MG, Atherton DJ. Failure of a new topical sodium cromoglycate formulation to improve atopic dermatitis [Letter]. Eur J Ped 1988;148:170.
51. Nagano T. Topical use of disodium cromoglycate nebulizer solution in adults with severe atopic dermatitis. Allergy Prac 1987;7:790-3.
52. Kimata H, Igarashi M. Inhibition of human allergic skin reactions in vivo by pretreatment with cromolyn (disodium cromoglycate). Allergy 1990;45: 393-395.
53. Walker C, Kagi MK, Ingold P, et al. Atopic dermatitis: correlation of peripheral blood T cell activation, eosinophilia and serum factors with clinical severity. Clin Exp Allergy 1993;23: 145-152.
54. Foreman JC, Pearce FL. Cromolyn and nedocromil. In: Middleton E, Reed CE, Ellis EF, et al, eds. Allergy: principles and practice. 4th ed. St. Louis, MO: Mosby Year Book, Inc, 1993: 926-940.
55. Schwartz L, Huff T. Biology of mast cells and basophils. In: Middleton E, Reed CE, Ellis EF, et al., eds. Allergy: principles and practice. 4th ed. St. Louis, MO: Mosby Year Book, Inc, 1993:135-168.
56. Matthews G, Neher E, Penner R. Chloride conductance activated by external agonists and internal messengers in rat peritoneal mast cells. J Physiol 1989; 418:131-144.
57. Romanin C, Reinsprecht M, Pecht I, Schlindler H. Immunologically activated chloride channels involved in degranulation of rat mucosal mast cells. EMBO J 1991;10:3603-3608.
58. Alton EW, Kingsleigh-Smith DJ, Munkonge FM, et al. Asthma prophylaxis agents alter the function of an airway epithelial chloride channel. Am J Respir Cell Mol Biol 1996;14: 380-387.
59. Cleophas TJM. A simple analysis of carryover studies with one-group interaction. Int J Clin Pharmacol Ther 1995;32:322-328.
60. Cleophas TJM. Underestimation of treatment effect in crossover trials. Angiology 1990;41:855-864.
61. Kim Y, Nakagawa N, Nakano K, et al. Stem cell factor in nasal polyposis and allergic rhinitis: increased expression by structural cells is suppressed by in vivo topical corticosteroids. J Allergy Clin Immunol 1997;100:389-99.
62. Finotto S, Mekori YA, Metcalfe DD. Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems. J Clin Invest 1997;99:1721-8.
63. Moore C, Ehlayel M, Inostroza J, Leiva L, et al. Elevated levels of soluble HLA class I (sHLA-I) in children with severe atopic dermatitis. Ann Allergy Asthma Immunol 1997;79: 113-118.